SCHEMBL23776145

SCHEMBL23776145

CCOC(=O)C1=CCN(S(=O)(=O)c2ccc(C)cc2)C1c1ccc(F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.52
TSHR P16473 3/20 0.46
LMNA P02545 3/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 4/20 0.45
GAA P10253 2/20 0.45
USP2 O75604 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
NOD2 Q9HC29 2/20 0.45
NOD1 Q9Y239 2/20 0.45
KMT2A Q03164 2/20 0.45
FKBP1A P62942 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23775874 0.97 L3MBTL1 (0.48) L3MBTL1TSHRLMNAALDH1A1GAA
SCHEMBL25491424 0.94 LMNA (0.50) L3MBTL1TSHRLMNAKDM4EALDH1A1
SCHEMBL23776109 0.92 ACHE (0.46) L3MBTL1TSHRKDM4EALDH1A1USP2
SCHEMBL23776079 0.92 ACHE (0.46) L3MBTL1TSHRKDM4EALDH1A1USP2
SCHEMBL23776071 0.92 L3MBTL1 (0.44) L3MBTL1KDM4EALDH1A1GAANPSR1
SCHEMBL23776110 0.92 L3MBTL1 (0.44) L3MBTL1KDM4EALDH1A1GAANPSR1
SCHEMBL23775892 0.92 NOD2 (0.50) L3MBTL1TSHRLMNAKDM4EALDH1A1
SCHEMBL25491366 0.90 GAA (0.50) L3MBTL1TSHRLMNAKDM4EALDH1A1
SCHEMBL25491432 0.90 USP2 (0.49) L3MBTL1TSHRLMNAKDM4EALDH1A1
SCHEMBL23776058 0.89 USP2 (0.51) L3MBTL1TSHRLMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150935-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CALCIUM ION HOMEOSTASIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-18 US disclosed
US-20230150935-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CALCIUM ION HOMEOSTASIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-18 US disclosed
WO-2021163493-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CALCIUM ION HOMEOSTASIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150935-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CALCIUM ION HOMEOSTASIS CHERP, ATP2A1, ATP2A3 L3MBTL1 2702/4885TSHR 4002/4885LMNA 1974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.